Product Introduction: CINALOC T

CINALOC T is a widely prescribed combination anti-hypertensive medication manufactured by Ajantha. Composed of 10mg of Cilnidipine (a calcium channel blocker) and 40mg of Telmisartan (an angiotensin II receptor blocker), it is indicated for the treatment of essential hypertension when monotherapy is insufficient, lowering blood pressure and reducing cardiovascular risks.

Primary Indications

• Treatment of essential hypertension (high blood pressure).
• Prevention of cardiovascular disease, reducing stroke and heart attack risk.
• Management of hypertension in patients with renal impairment.

Clinical Benefits

• Dual Action: Cilnidipine dilates blood vessels, while Telmisartan relaxes arteries, offering dual control.
• Renoprotection: Cilnidipine blocks L/N-type calcium channels, protecting kidneys from high pressure.
• Once-Daily Convenience: Offers reliable 24-hour blood pressure control with a single daily tablet.

Possible Side Effects

Common side effects may include:

• Dizziness, fatigue, headache, or orthostatic hypotension.
• Ankle swelling (peripheral edema) - though less common than with amlodipine.
• Mild gastrointestinal discomfort or transient renal impairment.

How to Take CINALOC T

• Take one tablet daily, with or without food, preferably in the morning.
• Swallow the tablet whole with a glass of water.
• Do not stop taking the drug abruptly, as blood pressure can rise quickly.

Mechanism of Action

CINALOC T works through two distinct mechanisms:

• Cilnidipine: Blocks L-type and N-type calcium channels, suppressing sympathetic nerve activity and causing blood vessels to dilate.
• Telmisartan: Selectively blocks the angiotensin II AT1 receptor, inhibiting vasoconstriction and aldosterone release.

Safety Warnings

• Pregnancy & Nursing: Strictly contraindicated. Angiotensin blockers can cause fetal injury or death.
• Liver Health: Since Telmisartan is extensively cleared by bile, use with caution in hepatic impairment.
• Kidney Health: Monitor renal function regularly, especially in patients with renal artery stenosis.

Patient Advice

• Avoid standing up too quickly from a sitting or lying position to prevent dizziness.
• Monitor your blood pressure regularly and keep a record.
• Avoid potassium supplements or salt substitutes unless directed by your physician.

Fact Box

Drug Interactions

• Simvastatin: Concomitant use may increase simvastatin levels.
• NSAIDs (Ibuprofen): May reduce the blood-pressure-lowering effect.
• Digoxin: May increase digoxin concentration in blood.

User Feedback

• Patients report highly satisfactory blood pressure control, with lower incidence of ankle swelling.
• Highly recommended by clinicians as a reliable combination therapy for essential hypertension.